Cargando…

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis

BACKGROUND: When psychosis develops in NMDA receptor (NMDAR) antibody encephalitis, it usually has an acute or subacute onset, and antipsychotic treatment may be ineffective and associated with adverse effects. Serum NMDAR antibodies have been reported in a minority of patients with first-episode ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollak, Thomas A., Vincent, Angela, Iyegbe, Conrad, Coutinho, Ester, Jacobson, Leslie, Rujescu, Dan, Stone, James, Jezequel, Julie, Rogemond, Veronique, Jamain, Stephane, Groc, Laurent, David, Anthony, Egerton, Alice, Kahn, Rene S., Honnorat, Jerome, Dazzan, Paola, Leboyer, Marion, McGuire, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Archival Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191702/ https://www.ncbi.nlm.nih.gov/pubmed/33536130 http://dx.doi.org/10.1016/j.biopsych.2020.11.014

Ejemplares similares

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
por: Jauhar, Sameer, et al.
Publicado: (2019)

The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
por: Ellul, Pierre, et al.
Publicado: (2017)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti—NMDA-receptor autoantibody
por: Gréa, Hélène, et al.
Publicado: (2017)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients
por: Jézéquel, Julie, et al.
Publicado: (2017)

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial
por: Susai, Subash Raj, et al.
Publicado: (2023)

Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis
por: Espana, Agnès, et al.
Publicado: (2021)

Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis
por: Vissink, Conrad E., et al.
Publicado: (2021)

31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS
por: Dazzan, Paola, et al.
Publicado: (2018)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction
por: Manto, Mario, et al.
Publicado: (2010)

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model
por: Sigvard, Anne K., et al.
Publicado: (2022)

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics
por: Gréa, Hélène, et al.
Publicado: (2019)

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Familial risk and childhood adversity interplay in the onset of psychosis
por: Trotta, Antonella, et al.
Publicado: (2015)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

Peripheral immune markers and antipsychotic non-response in psychosis
por: Enache, Daniela, et al.
Publicado: (2021)

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
por: Pollak, Thomas A., et al.
Publicado: (2020)

Changes in the Frontotemporal Cortex and Cognitive Correlates in First-Episode Psychosis
por: Gutiérrez-Galve, Leticia, et al.
Publicado: (2010)

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study
por: Merritt, Kate, et al.
Publicado: (2020)

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal (1)H-MRS Studies
por: Egerton, Alice, et al.
Publicado: (2017)

Regulation of membrane NMDA receptors by dynamics and protein interactions
por: Petit-Pedrol, Mar, et al.
Publicado: (2020)

Hippocampal Network Dysfunction in Early Psychosis: A 2-Year Longitudinal Study
por: Avery, Suzanne N., et al.
Publicado: (2022)

T40. GLYCERYL TRINITRATE IN FIRST EPISODE PSYCHOSIS UNMEDICATED WITH ANTIPSYCHOTICS: A RANDOMISED CONTROLLED FEASIBILITY STUDY
por: Merritt, Kate, et al.
Publicado: (2020)

Persistent Childhood and Adolescent Anxiety and Risk for Psychosis: A Longitudinal Birth Cohort Study
por: Morales-Muñoz, Isabel, et al.
Publicado: (2022)

A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
por: ter Hark, Sophie E, et al.
Publicado: (2020)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

38.1 IMPACT OF ANTI-NMDA RECEPTOR AUTOANTIBODIES FROM PSYCHOTIC PATIENTS ON THE GLUTAMATE SYNAPSE
por: Groc, Laurent
Publicado: (2018)

Estimating the Association Between Exposome and Psychosis as Well as General Psychopathology: Results From the ABCD Study
por: Pries, Lotta-Katrin, et al.
Publicado: (2022)

Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism
por: Genius, Just, et al.
Publicado: (2013)

A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation
Publicado: (2014)

Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure
por: Deans, P.J. Michael, et al.
Publicado: (2017)

Regional Brain Correlates of Beta Bursts in Health and Psychosis: A Concurrent Electroencephalography and Functional Magnetic Resonance Imaging Study
por: Briley, Paul M., et al.
Publicado: (2021)

Systematic review of the association between adverse life events and the onset and relapse of postpartum psychosis
por: Reilly, Thomas J., et al.
Publicado: (2023)

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
por: Egerton, Alice, et al.
Publicado: (2020)

T104. ASSESSING THE UTILITY OF COPULA FUNCTIONS FOR RISK PREDICTION OF PSYCHOSIS
por: Zhang, Landan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5me3cob1kc30d79ms6ngv08e2u